Favor’d ALKz · Product Pipeline
What’s Brewing
Every product passes through the same pipeline: formulation, third-party lab verification, then launch. Here's exactly where everything stands — including what hasn't dropped yet.
Just Went Live
Passion Fruit MGM
Pressed Tablet · High-Purity MGM · 25/50/100/200ct
Lab-Verified · Cora Science
14mg MGM (dihydro-7-OH) per tablet · near-zero standard alkaloids
Final CORA COA in: 14mg MGM (dihydro-7-hydroxymitragynine) per tablet, full safety panel passed. Awaiting final pricing + pack options.
Strawberry Watermelon Pseudo
Pressed Tablet · Pseudoindoxyl
Dialing to Target
Target 10–12mg pseudoindoxyl per tablet · final COA publishes at launch batch
Blue Raspberry (30mg Quad)
Pressed Tablet · 30mg 7-OH · Quad-Score
Lab-Verified
30mg 7-OH — input batch verified (Mango lot: 30.9mg)
Strawberry (30mg Quad)
Pressed Tablet · 30mg 7-OH · Quad-Score
Lab-Verified
30mg 7-OH — input batch verified (Mango lot: 30.9mg)
In Formulation
Reveal Pending
100mg Mitragynine Tab
Thai-Style Pressed Tablet · High-dose mitragynine
Target Potency
Target: 100 mg mitragynine per tablet (via Special Blend 69)
- 100 mg mitragynine target
- Source: Special Blend 69 (69.1% mit)
- Ref: Mixed Berry tested 15.31mg @ 20mg tgt (76.5% recovery)
In development — a mitragynine-based tablet targeting a compliant formulation in the event of a federal 7-OH regulatory shift.
Mitragynine is the primary kratom-leaf alkaloid and is not named in the DEA's 7-OH scheduling action — positioning this as a compliant option should 7-OH face federal restriction.